Intermediate-half-life metabolites as systemic relay nodes in metabolic disease

Metabolic stress within one organ can have consequences far beyond its site of origin. In metabolic dysfunction-associated steatotic liver disease (MASLD), reactive carbonyl species, purine metabolites, and nitric oxide-related intermediates provide a basis for examining how metabolic disturbances may extend across tissues. Selected metabolites may act as systemic relay nodes when their production, persistence, and transport permit exposure beyond the source tissue. A broadly minutes-to-hours timescale offers a useful starting point for this hypothesis, while chemical form, reactivity, tissue uptake, and clearance determine the reach of each candidate. Plasma disappearance, whole-body elimination, intracellular persistence, and covalent-adduct persistence describe distinct processes that shape the interpretation of measured exposure. Mechanistic studies, analytical measurements, and clinical interventions together inform the links between local stress and distant effects. Emerging AI and multi-omics approaches may help characterize the resulting metabolic heterogeneity. Viewed through this framework, metabolite kinetics become a bridge between molecular mechanisms and candidate approaches to patient stratification, connecting the duration and distribution of exposure with potential sites of intervention.